New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Men with low-/intermediate-risk prostate cancer benefit from fewer, higher-dose radiation treatments

Men with low-/intermediate-risk prostate cancer benefit from fewer, higher-dose radiation treatments

byAmerican Society for Radiation OncologyStereotactic body radiation therapy (SBRT) is a safe and effective treatment for men with low- and intermediate-risk prostate cancer, according to a long
Oncology December 18,2023
Men with low-/intermediate-risk prostate cancer benefit from fewer, higher-dose radiation treatments

Men with low-/intermediate-risk prostate cancer benefit from fewer, higher-dose radiation treatments

byAmerican Society for Radiation OncologyStereotactic body radiation therapy (SBRT) is a safe and effective treatment for men with low- and intermediate-risk prostate cancer, according to a long
Oncology December 18,2023
Variants in BRCA1/2 and MMR genes in children with cancer

Variants in BRCA1/2 and MMR genes in children with cancer

by Stefan Zorn, Medizinische Hochschule HannoverProfessor Dr. Christian Kratz, initiator of the international study that investigated the cancer risk of disease-relevant variants in BRCA1/2 and MMR ge
Oncology December 18,2023
Variants in BRCA1/2 and MMR genes in children with cancer

Variants in BRCA1/2 and MMR genes in children with cancer

by Stefan Zorn, Medizinische Hochschule HannoverProfessor Dr. Christian Kratz, initiator of the international study that investigated the cancer risk of disease-relevant variants in BRCA1/2 and MMR ge
Oncology December 18,2023
Pelvic lymph node radiation provides significant benefit for prostate cancer patients

Pelvic lymph node radiation provides significant benefit for prostate cancer patients

byAmerican Society for Radiation OncologyThe first report of a large international clinical trial shows that, for men who show signs of prostate cancer after surgical removal of their prostates,
Oncology December 18,2023
Pelvic lymph node radiation provides significant benefit for prostate cancer patients

Pelvic lymph node radiation provides significant benefit for prostate cancer patients

byAmerican Society for Radiation OncologyThe first report of a large international clinical trial shows that, for men who show signs of prostate cancer after surgical removal of their prostates,
Oncology December 18,2023
Radiation therapy cuts low risk of recurrence in half for patients with 'good risk' breast cancer

Radiation therapy cuts low risk of recurrence in half for patients with 'good risk' breast cancer

by NRG OncologyA subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservation surgery but can lower that risk even further with radiationtherapy
Oncology December 18,2023
Radiation therapy cuts low risk of recurrence in half for patients with 'good risk' breast cancer

Radiation therapy cuts low risk of recurrence in half for patients with 'good risk' breast cancer

by NRG OncologyA subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservation surgery but can lower that risk even further with radiationtherapy
Oncology December 18,2023
Blood test biopsy for kids with brain tumors is simple, safe way to see if treatment is working

Blood test biopsy for kids with brain tumors is simple, safe way to see if treatment is working

byUniversity of California, San FranciscoA new blood test for children with brain tumors offers a safer approach than surgical biopsies and may allow doctors to measure the effectiveness of trea
Oncology December 18,2023
Blood test biopsy for kids with brain tumors is simple, safe way to see if treatment is working

Blood test biopsy for kids with brain tumors is simple, safe way to see if treatment is working

byUniversity of California, San FranciscoA new blood test for children with brain tumors offers a safer approach than surgical biopsies and may allow doctors to measure the effectiveness of trea
Oncology December 18,2023
Barriers to early clinical trial access for adolescents and young adults still exist

Barriers to early clinical trial access for adolescents and young adults still exist

byEuropean Society for Medical OncologyYoung cancer patients at the crossroads of childhood and adulthood seem to be stuck in a treatment impasse. A study to be presented at the ESMO 2018 Congre
Oncology December 18,2023
Barriers to early clinical trial access for adolescents and young adults still exist

Barriers to early clinical trial access for adolescents and young adults still exist

byEuropean Society for Medical OncologyYoung cancer patients at the crossroads of childhood and adulthood seem to be stuck in a treatment impasse. A study to be presented at the ESMO 2018 Congre
Oncology December 18,2023
How cancer cells die: Scientists explore new pathways of pyroptosis, killer kin of apoptosis

How cancer cells die: Scientists explore new pathways of pyroptosis, killer kin of apoptosis

by Delthia Ricks , Medical XpressLymphoid BLaER1 cells undergo PANX1-dominant lysis. (A to C) BLaER1 cells were treated with topoisomerase poisons doxorubicin (2 μM) or etoposide (50 μM) for 24 hours.
Oncology December 18,2023
How cancer cells die: Scientists explore new pathways of pyroptosis, killer kin of apoptosis

How cancer cells die: Scientists explore new pathways of pyroptosis, killer kin of apoptosis

by Delthia Ricks , Medical XpressLymphoid BLaER1 cells undergo PANX1-dominant lysis. (A to C) BLaER1 cells were treated with topoisomerase poisons doxorubicin (2 μM) or etoposide (50 μM) for 24 hours.
Oncology December 18,2023
Potential therapy for treatment-resistant hypothyroidism proves effective in lab study

Potential therapy for treatment-resistant hypothyroidism proves effective in lab study

byRush University Medical CenterA new "metal-coordinated" drug-delivery technology potentially could be used to supplement the standard therapy for hypothyroidism, which affects nearly
Diabetes & Endocrinology December 18,2023
Potential therapy for treatment-resistant hypothyroidism proves effective in lab study

Potential therapy for treatment-resistant hypothyroidism proves effective in lab study

byRush University Medical CenterA new "metal-coordinated" drug-delivery technology potentially could be used to supplement the standard therapy for hypothyroidism, which affects nearly
Diabetes & Endocrinology December 18,2023
HPV blood test shows promise for tracking head and neck cancer after treatment

HPV blood test shows promise for tracking head and neck cancer after treatment

byUNC Lineberger Comprehensive Cancer CenterA new blood test developed by University of North Carolina Lineberger Comprehensive Cancer Center researchers shows promise for tracking HPV-linked he
Oncology December 18,2023
HPV blood test shows promise for tracking head and neck cancer after treatment

HPV blood test shows promise for tracking head and neck cancer after treatment

byUNC Lineberger Comprehensive Cancer CenterA new blood test developed by University of North Carolina Lineberger Comprehensive Cancer Center researchers shows promise for tracking HPV-linked he
Oncology December 18,2023
How cancer cells move and metastasize is influenced by the fluids surrounding them

How cancer cells move and metastasize is influenced by the fluids surrounding them

by Yizeng Li,The ConversationCredit: CC0 Public DomainCell migration, or how cells move in the body, is essential to both normal body function and disease progression. Cell movement is what allo
Oncology December 18,2023
How cancer cells move and metastasize is influenced by the fluids surrounding them

How cancer cells move and metastasize is influenced by the fluids surrounding them

by Yizeng Li,The ConversationCredit: CC0 Public DomainCell migration, or how cells move in the body, is essential to both normal body function and disease progression. Cell movement is what allo
Oncology December 18,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com